Evusheld drug approved for use in people aged 12 and older who are immunocompromised or for whom COVID-19 vaccination is not recommended.
Health Canada has authorized a drug developed by AstraZeneca to prevent COVID-19 infections.
Evusheld has been cleared for people aged 12 and older who have a compromised immune system and are unlikely to get an adequate response to a COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended.
The medication contains lab-made antibodies designed to remain in the body for months, which officials say will contain the virus if there is an infection.
The therapy has also been authorized in the United States and has been recommended by the European Medicines Agency.

Multiple Charges Laid after Thefts in Tillsonburg
CASS Offering Unique Program to Students
PJHL Preview - Jan. 30th to Feb. 1st
Woodstock Bowler Heading to Special Olympics
Dog Bite Investigation in Tillsonburg
Interview with the Warden - January 29th, 2026
Trevor Birtch Trial Daily Recap - Case 2
11 People Charged in Massive Drug Bust
Another Cold Warning for Oxford County
Chilly Charlie Returns on Monday
Khanna Shines a Light on Oxford County Superstars
WFD Responds to Structure Fire
WPS Appoints New Deputy Chief
TMMC Woodstock Begins Production of Sixth Gen RAV4
Oxford OPP Briefs - January 28th, 2026
More Weather Alerts for Oxford County
Thrive Oxford Honoured at ROMA
Tip Tuesday with the Oxford OPP - January 2026
Members Needed for Tillsonburg Housing Advisory Committee
UPDATE: Ottawa Approves Plan to Move Marineland's Whales and Dolphins
Comments
Add a comment